About Fonar (NASDAQ:FONR)
Fonar Corporation (Fonar) is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilizes MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions and injuries. The Company operates its business through two segments: Medical Equipment segment, and Physician Management and Diagnostic Services segment. Its Medical Equipment segment is conducted through Fonar. Its Physician Management and Diagnostic Services segment is conducted through its subsidiary Health Management Company of America (HMCA). It offers Upright MRI, which is used to scan any part of the body. The Upright MRI allows patients to be scanned in various conditions, such as standing, sitting, bending or lying down in any position. The Company offers SMART, where scanning allows for same-scan customization of 63 slices.
Industry, Sector and Symbol
Industry MED PRODS
Trailing P/E Ratio8.66
Forward P/E RatioN/A
Sales & Book Value
Annual Sales$78.04 million
Price / Sales2.14
Cash Flow$3.83 per share
Price / Cash6.94
Book Value$13.37 per share
Price / Book1.99
Net Income$19.62 million
Return on Equity23.26%
Return on Assets19.57%
Fonar (NASDAQ:FONR) Frequently Asked Questions
What is Fonar's stock symbol?
Fonar trades on the NASDAQ under the ticker symbol "FONR."
How were Fonar's earnings last quarter?
Fonar Co. (NASDAQ:FONR) posted its quarterly earnings data on Monday, February, 12th. The medical equipment provider reported $0.70 earnings per share for the quarter. The medical equipment provider had revenue of $20.17 million for the quarter. Fonar had a net margin of 23.44% and a return on equity of 23.26%. View Fonar's Earnings History.
When will Fonar make its next earnings announcement?
Who are some of Fonar's key competitors?
Some companies that are related to Fonar include Pacific Biosciences of California (PACB), RTI Surgical (RTIX), GenMark Diagnostics (GNMK), Rockwell Medical (RMTI), Evolus (EOLS), Chimerix (CMRX), Quotient (QTNT), Pulse Biosciences (PLSE), Fluidigm (FLDM), T2 Biosystems (TTOO), Cogentix Medical (CGNT), Cytosorbents (CTSO), Orthopediatrics (KIDS), Aceto (ACET), Veracyte (VCYT), Restoration Robotics (HAIR), Sientra (SIEN) and Helius Medical Technologies (HSDT).
Who are Fonar's key executives?
Fonar's management team includes the folowing people:
- Raymond V. Damadian, Chairman of the Board (Age 79)
- Timothy R. Damadian, President, Chief Executive Officer (Age 44)
- Claudette J. V. Chan, Secretary, Director (Age 77)
- Charles N. O'Data, Lead Independent Director (Age 79)
- Robert J. Janoff, Independent Director (Age 88)
- Ronald G. Lehman, Independent Director (Age 39)
Has Fonar been receiving favorable news coverage?
News coverage about FONR stock has trended positive this week, according to Accern Sentiment. The research firm ranks the sentiment of press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Fonar earned a media sentiment score of 0.27 on Accern's scale. They also gave news stories about the medical equipment provider an impact score of 44.55 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future.
Who are Fonar's major shareholders?
Fonar's stock is owned by many different of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (7.37%), BlackRock Inc. (4.95%), Bowling Portfolio Management LLC (0.94%), Bailard Inc. (0.87%), Geode Capital Management LLC (0.85%) and Deutsche Bank AG (0.68%). Company insiders that own Fonar stock include Raymond V Damadian and Robert J Janoff. View Institutional Ownership Trends for Fonar.
Which institutional investors are selling Fonar stock?
FONR stock was sold by a variety of institutional investors in the last quarter, including Geode Capital Management LLC, Two Sigma Advisers LP and TIAA CREF Investment Management LLC. View Insider Buying and Selling for Fonar.
Which institutional investors are buying Fonar stock?
FONR stock was acquired by a variety of institutional investors in the last quarter, including Bowling Portfolio Management LLC, Bailard Inc., Deutsche Bank AG, Renaissance Technologies LLC, Wells Fargo & Company MN, BlackRock Inc. and SG Americas Securities LLC. View Insider Buying and Selling for Fonar.
How do I buy shares of Fonar?
Shares of FONR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Fonar's stock price today?
One share of FONR stock can currently be purchased for approximately $26.55.
How big of a company is Fonar?
Fonar has a market capitalization of $162.85 million and generates $78.04 million in revenue each year. The medical equipment provider earns $19.62 million in net income (profit) each year or $2.90 on an earnings per share basis. Fonar employs 500 workers across the globe.
How can I contact Fonar?
Fonar's mailing address is 110 Marcus Drive, Melville NY, 11747. The medical equipment provider can be reached via phone at 631-694-2929 or via email at [email protected]
MarketBeat Community Rating for Fonar (FONR)MarketBeat's community ratings are surveys of what our community members think about Fonar and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Fonar (NASDAQ:FONR) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Fonar (NASDAQ:FONR) Earnings History and Estimates Chart
Fonar (NASDAQ FONR) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/12/2018||Q2 2018||$0.70||$20.17 million||View||N/A|
|11/9/2017||Q1 2018||$0.54||$19.33 million||View||N/A|
|9/14/2017||Q4 2017||$0.87||$20.89 million||View||N/A|
|5/10/2017||Q3 2017||$0.88||$20.01 million||View||N/A|
|2/9/2017||Q2 2017||$0.63||$18.40 million||View||N/A|
|11/9/2016||Q1 2017||$0.54||$18.73 million||View||N/A|
|9/19/2016||Q4 2016||$0.96||$18.77 million||View||N/A|
|5/10/2016||Q3 2016||$0.45||$18.62 million||View||N/A|
|2/9/2016||Q2 2016||$0.53||$18.37 million||View||N/A|
|11/9/2015||Q1 2016||$0.43||$17.61 million||View||N/A|
|9/14/2015||Q4 2015||$0.86||$16.88 million||View||N/A|
|5/11/2015||Q3 2015||$0.31||$17.10 million||View||N/A|
|2/9/2015||Q2 2015||$0.40||$17.09 million||View||N/A|
|11/10/2014||Q115||$0.38||$16.83 million||$17.99 million||View||N/A|
|9/15/2014||Q4 2014||$0.62||$17.02 million||View||N/A|
|5/15/2014||Q314||$0.26||$11.64 million||$17.04 million||View||N/A|
|2/14/2014||Q214||$0.33||$9.60 million||$17.60 million||View||N/A|
|11/15/2013||Q114||$0.37||$9.50 million||$16.80 million||View||N/A|
|10/15/2013||Q4 2013||$0.74||$18.38 million||View||N/A|
|5/15/2013||Q3 2013||$0.17||$9.50 million||$11.60 million||View||N/A|
|2/14/2013||Q412||$0.21||$9.33 million||$9.61 million||View||N/A|
|11/15/2012||Q312||$0.22||$9.60 million||$9.50 million||View||N/A|
Fonar (NASDAQ:FONR) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Fonar (NASDAQ:FONR)
No dividend announcements for this company have been tracked by MarketBeat.com
Fonar (NASDAQ FONR) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 8.33%
Institutional Ownership Percentage: 48.17%
Fonar (NASDAQ FONR) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|2/20/2018||Robert J. Janoff||Director||Sell||1,000||$25.73||$25,730.00|| |
|6/16/2016||Raymond V Damadian||Treasurer||Sell||2,700||$19.09||$51,543.00||103,702|| |
|4/14/2016||Raymond V Damadian||Treasurer||Sell||2,000||$15.01||$30,020.00||106,402|| |
|5/22/2015||Raymond V Damadian||President||Sell||4,550||$10.66||$48,503.00|| |
|1/9/2014||Robert J Janoff||Director||Sell||1,000||$26.32||$26,320.00|| |
|12/13/2013||Raymond V Damadian||Chairman||Sell||3,350||$14.93||$50,015.50|| |
|6/19/2013||Raymond V Damadian||Chairman||Sell||4,000||$6.18||$24,720.00|| |
Fonar (NASDAQ FONR) News Headlines
|Robert J. Janoff Sells 1,000 Shares of Fonar Co. (FONR) Stock|
www.americanbankingnews.com - February 21 at 7:10 PM
|Free Post Earnings Research Report: Boston Scientific’s Quarterly Revenues Jumped 9.9%; Adjusted EPS Advanced 13.3%|
finance.yahoo.com - February 21 at 8:00 AM
|FONAR Announces Fiscal 2018 2nd Quarter and Six Months Financial Results|
finance.yahoo.com - February 12 at 7:58 AM
|Is It Time To Buy Fonar Corporation (NASDAQ:FONR) Based Off Its PE Ratio?|
finance.yahoo.com - February 8 at 7:51 AM
|Fonar (FONR) Scheduled to Post Quarterly Earnings on Wednesday|
www.americanbankingnews.com - January 31 at 2:28 AM
|One corner of the stock market sees even crazier trading than bitcoin|
www.businessinsider.com - January 12 at 4:51 PM
|ETFs with exposure to FONAR Corp. : December 28, 2017|
finance.yahoo.com - December 28 at 3:40 PM
|FONAR Corp. :FONR-US: Earnings Analysis: Q1, 2018 By the Numbers : December 28, 2017|
finance.yahoo.com - December 28 at 9:38 AM
|ETFs with exposure to FONAR Corp. : December 14, 2017|
finance.yahoo.com - December 14 at 5:33 PM
|ETFs with exposure to FONAR Corp. : November 27, 2017|
finance.yahoo.com - November 27 at 5:46 PM
|Fonar is Now Oversold (FONR)|
www.thestreet.com - November 22 at 4:56 AM
|ETFs with exposure to FONAR Corp. : November 17, 2017|
finance.yahoo.com - November 18 at 8:47 AM
|FONAR Announces First Quarter Earnings of Fiscal 2018|
finance.yahoo.com - November 10 at 5:00 PM
|ETFs with exposure to FONAR Corp. : November 6, 2017|
finance.yahoo.com - November 6 at 10:58 PM
|Fonar Corporation (FONR) Scheduled to Post Earnings on Tuesday|
www.americanbankingnews.com - October 31 at 9:56 AM
|ETFs with exposure to FONAR Corp. : October 24, 2017|
finance.yahoo.com - October 25 at 12:14 AM
|ETFs with exposure to FONAR Corp. : October 13, 2017|
finance.yahoo.com - October 13 at 4:22 PM
|FONAR Corp. :FONR-US: Earnings Analysis: Q4, 2017 By the Numbers : October 5, 2017|
finance.yahoo.com - October 5 at 5:56 PM
|Fonar Corp (FONR) Files 10-K for the Fiscal Year Ended on June 30, 2017|
finance.yahoo.com - October 2 at 2:27 PM
|FONAR Corp. :FONR-US: Earnings Analysis: 2017 By the Numbers : September 29, 2017|
finance.yahoo.com - October 2 at 2:27 PM
|ETFs with exposure to FONAR Corp. : October 2, 2017|
finance.yahoo.com - October 2 at 2:27 PM
|FONAR Announces Fiscal 2017 Year-End Earnings|
finance.yahoo.com - September 14 at 7:23 PM
|Fonar Corporation (FONR) Scheduled to Post Quarterly Earnings on Monday|
www.americanbankingnews.com - September 11 at 1:46 AM
|ETFs with exposure to FONAR Corp. : August 8, 2017|
finance.yahoo.com - August 8 at 6:28 PM
|Action Was Under the Surface in Monday's Market|
finance.yahoo.com - July 17 at 7:38 PM
|FONAR Celebrates Two Milestones: the 40th Birthday of the MRI Industry and the Impact of Joining the Russell 3000® Index|
finance.yahoo.com - July 10 at 6:41 PM
|ETFs with exposure to FONAR Corp. : July 10, 2017|
finance.yahoo.com - July 10 at 6:41 PM
|BRIEF-FONAR Q3 earnings per share $0.88|
www.reuters.com - May 11 at 3:26 AM
|Fonar posts 3Q profit|
marketbeat.com - May 10 at 10:48 AM
|BRIEF-Fonar reports Q2 EPS $0.63|
www.reuters.com - February 10 at 10:55 PM
|FONAR CORP Files SEC form 10-Q, Quarterly Report|
biz.yahoo.com - February 9 at 5:53 PM
|FONAR CORP Files SEC form 10-K, Annual Report|
biz.yahoo.com - September 29 at 10:04 AM
|FONAR CORP Files SEC form 8-K, Results of Operations and Financial Condition|
biz.yahoo.com - September 21 at 9:19 AM
Fonar (NASDAQ:FONR) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Fonar (NASDAQ:FONR) Income Statement, Balance Sheet and Cash Flow Statement
Fonar (NASDAQ FONR) Stock Chart for Thursday, March, 22, 2018